158 related articles for article (PubMed ID: 28296597)
1. Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone.
Zhang Y; Xu YY; Yao CB; Li JT; Zhao XN; Yang HB; Zhang M; Yin M; Chen J; Lei QY
Autophagy; 2017 Mar; 13(3):538-553. PubMed ID: 28296597
[TBL] [Abstract][Full Text] [Related]
2. Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer.
Huang H; Liu R; Huang Y; Feng Y; Fu Y; Chen L; Chen Z; Cai Y; Zhang Y; Chen Y
Aging (Albany NY); 2020 Jul; 12(14):14699-14717. PubMed ID: 32678070
[TBL] [Abstract][Full Text] [Related]
3. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
Lu X; Ma P; Shi Y; Yao M; Hou L; Zhang P; Jiang L
Mol Cell Endocrinol; 2015 Feb; 401():1-11. PubMed ID: 25448063
[TBL] [Abstract][Full Text] [Related]
4. Acetylation of translationally controlled tumor protein promotes its degradation through chaperone-mediated autophagy.
Bonhoure A; Vallentin A; Martin M; Senff-Ribeiro A; Amson R; Telerman A; Vidal M
Eur J Cell Biol; 2017 Mar; 96(2):83-98. PubMed ID: 28110910
[TBL] [Abstract][Full Text] [Related]
5. Electromagnetic Field (EMF) Radiation Alters Estrogen Release from the Pig Myometrium during the Peri-Implantation Period.
Drzewiecka EM; Kozlowska W; Zmijewska A; Wydorski PJ; Franczak A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805726
[TBL] [Abstract][Full Text] [Related]
6. Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4).
Frasinyuk MS; Zhang W; Wyrebek P; Yu T; Xu X; Sviripa VM; Bondarenko SP; Xie Y; Ngo HX; Morris AJ; Mohler JL; Fiandalo MV; Watt DS; Liu C
Org Biomol Chem; 2017 Sep; 15(36):7623-7629. PubMed ID: 28868548
[TBL] [Abstract][Full Text] [Related]
7. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy.
Yamashita S; Hattori N; Fujii S; Yamaguchi T; Takahashi M; Hozumi Y; Kogawa T; El-Omar O; Liu YY; Arai N; Mori A; Higashimoto H; Ushijima T; Mukai H
Sci Rep; 2020 Sep; 10(1):15530. PubMed ID: 32968149
[TBL] [Abstract][Full Text] [Related]
9. HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity.
Arai N; Hattori N; Yamashita S; Liu YY; Ebata T; Takeuchi C; Takeshima H; Fujii S; Kondo H; Mukai H; Ushijima T
Breast Cancer Res Treat; 2023 Sep; 201(2):317-328. PubMed ID: 37378696
[TBL] [Abstract][Full Text] [Related]
10. Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation.
Fujii S; Yamashita S; Yamaguchi T; Takahashi M; Hozumi Y; Ushijima T; Mukai H
Oncotarget; 2017 Mar; 8(12):19039-19048. PubMed ID: 28186977
[TBL] [Abstract][Full Text] [Related]
11. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
12. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
13. The Peroxisomal Localization of Hsd17b4 Is Regulated by Its Interaction with Phosphatidylserine.
Lee SA; Lee J; Kim K; Moon H; Min C; Moon B; Kim D; Yang S; Park H; Lee G; Park R; Park D
Mol Cells; 2021 Apr; 44(4):214-222. PubMed ID: 33935042
[TBL] [Abstract][Full Text] [Related]
14. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells.
Kruchten P; Werth R; Bey E; Oster A; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):200-6. PubMed ID: 19429452
[TBL] [Abstract][Full Text] [Related]
16. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
17. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
[TBL] [Abstract][Full Text] [Related]
18. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.
Liu R; Zeng LW; Gong R; Yuan F; Shu HB; Li S
Nat Commun; 2021 Jul; 12(1):4227. PubMed ID: 34244482
[TBL] [Abstract][Full Text] [Related]
20. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1.
Suzuki J; Nakajima W; Suzuki H; Asano Y; Tanaka N
Biochem Biophys Res Commun; 2017 Jan; 482(4):1334-1340. PubMed ID: 27939888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
